{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:55:08Z","timestamp":1791395708916,"version":"4.3.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Agence Nationale pour la Recherche (ANR)"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm, R\u00e9seau de recherche clinique et en sant\u00e9 des populations)"},{"name":"Programme Hospitalier de Recherche Clinique (PHRC)"},{"name":"Royal Society Wolfson research Merit Award"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.09.052","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T10:45:37Z","timestamp":1381747537000},"page":"5856-5862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Validation of the French national health insurance information system as a tool in vaccine safety assessment: Application to febrile convulsions after pediatric measles\/mumps\/rubella immunization"],"prefix":"10.1016","volume":"31","author":[{"given":"Matthieu","family":"Hanf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Quantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paddy","family":"Farrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Benzenine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Mounia","family":"Hocine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Velten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Tubert-Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2013.09.052_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","article-title":"Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review","volume":"31","author":"Ozawa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0010","series-title":"State of the world's vaccines and immunization","author":"Maurice","year":"2009"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0015","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.vaccine.2004.01.010","article-title":"A global perspective on vaccine safety","volume":"22","author":"Duclos","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0264-410X(90)90042-K","article-title":"Role of epidemiology in vaccine policy","volume":"8","author":"Begg","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0025","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0264-410X(00)00467-9","article-title":"Adverse events and vaccination \u2013 the lack of power and predictability of infrequent events in pre-licensure study","volume":"19","author":"Jacobson","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0030","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/14760584.2.1.21","article-title":"Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines","volume":"2","author":"Verstraeten","year":"2003","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(95)90471-9","article-title":"A new method for active surveillance of adverse events from diphtheria\/tetanus\/pertussis and measles\/mumps\/rubella vaccines","volume":"345","author":"Farrington","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","article-title":"French national health insurance information system and the permanent beneficiaries sample","volume":"58","author":"Tuppin","year":"2010","journal-title":"Revue d Epidemiologie et de Sante Publique"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.1912","article-title":"Pharmacoepidemiological research using French reimbursement databases: yes we can!","volume":"19","author":"Martin-Latry","year":"2010","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0060","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/S0264-410X(03)00271-8","article-title":"Unintended events following immunization with MMR: a systematic review","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","article-title":"The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine","volume":"345","author":"Barlow","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.292.3.351","article-title":"MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis","volume":"292","author":"Vestergaard","year":"2004","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0075","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/aje\/kwk045","article-title":"Risks of convulsion and aseptic meningitis following measles\u2013mumps\u2013rubella vaccination in the United Kingdom","volume":"165","author":"Miller","year":"2007","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0080","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.vaccine.2010.04.021","article-title":"Use of the Australian Childhood Immunisation Register for vaccine safety data linkage","volume":"28","author":"Gold","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0085","first-page":"163","article-title":"Haut Conseil de la sant\u00e9 publique 2012 vaccination schedule and recommendations from the \u201cHaut Conseil de la sant\u00e9 publique\u201d in France","volume":"14\u201315","year":"2012","journal-title":"Bulletin \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0090","first-page":"31","article-title":"Vaccination coverage estimated based on data found in 24th month health certificates of infants France, 2004\u20132007","author":"Fonteneau","year":"2010","journal-title":"Bulletin \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0095","series-title":"The vaccination policy in France","author":"Blanc","year":"2007"},{"key":"10.1016\/j.vaccine.2013.09.052_bib0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13013157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13013157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:19:51Z","timestamp":1759400391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13013157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":20,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X13013157"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the French national health insurance information system as a tool in vaccine safety assessment: Application to febrile convulsions after pediatric measles\/mumps\/rubella immunization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}